Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid
Brain and Behavior · 2023
DOI: 10.1002/brb3.3224 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2023. Verfasst von Maryam Saadat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Sciences, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran. Hauptthemen laut MEDLINE: Autistic Disorder, Autism Spectrum Disorder, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Semnan University of Medical Sciences and Health Services.
Abstract (Originalsprache)
Background
Prenatal exposure to valproic acid (VPA) may enhance the risk of autism spectrum disorder (ASD) in children. This study investigated the effect of Prangos ferulacea (L.) on behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
Methods
Pregnant rats received VPA (600 mg/kg, intraperitoneally [i.p.]) or saline on gestational day 12.5 (E 12.5). Starting from the 30th postnatal day (PND 30), the pups were i.p. administered Prangos ferulacea (PF, 100 and 200 mg/kg), or the vehicle, daily until PND 58. On PND 30 and 58, various behavioral tasks were used to evaluate pups, including the open field, elevated plus‐maze, hot‐plate, and rotarod test. On PND 65, the animals were euthanized, and their brains were removed for histopathological and biochemical assay.
Results
Prenatal exposure to VPA caused significant behavioral changes in the offspring, reversed by administering an extract of Prangos ferulacea (L.). Additionally, prenatal VPA administration resulted in increased levels of malondialdehyde and deficits in antioxidant enzyme activities in the hippocampus, including catalase and glutathione, ameliorated by PF. Likewise, postnatal treatment with PF improved VPA‐induced dysregulation of Bax and Blc2 in the hippocampus and reduced neuronal death in CA1, CA3, and dentate gyrus.
Conclusion
The findings of this study suggest that postnatal administration of PF can prevent VPA‐induced ASD‐like behaviors by exhibiting antiapoptotic and antioxidant properties. Therefore, PF may have the potential as an adjunct in the management of ASD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomical Sciences, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
- Research Center of Physiology, Semnan University of Medical Sciences, Semnan, Iran.
- Nervous System Stem Cells Research Center, Semnan University of Medical Sciences, Semnan, Iran.
- Department of Physiology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
ORCID-Profile: Hamid Reza Sameni
Förderung
- Semnan University of Medical Sciences and Health Services
Zitieren
APA
Saadat, M., Taherian, A. A., Aldaghi, M. R., Raise-Abdullahi, P., Sameni, H. R., & Vafaei, A. A. (2023). Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid. Brain and Behavior. https://doi.org/10.1002/brb3.3224
Vancouver
Saadat M, Taherian AA, Aldaghi MR, Raise-Abdullahi P, Sameni HR, Vafaei AA. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid. Brain and Behavior. 2023. doi:10.1002/brb3.3224
BibTeX
@article{Saadat2023,
author = {Saadat, Maryam and Taherian, Abbas Ali and Aldaghi, Mohammad Reza and Raise-Abdullahi, Payman and Sameni, Hamid Reza and Vafaei, Abbas Ali},
title = {Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid},
journal = {Brain and Behavior},
year = {2023},
doi = {10.1002/brb3.3224}
}
EUVIMED